Get the Stockscreener App
2.99
11.15%
0.30
After Hours:
3.05
0.06
+2.01%
Verastem Inc stock is traded at $2.99, with a volume of 1.44M.
It is up +11.15% in the last 24 hours and up +19.60% over the past month.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
See More
Previous Close:
$2.69
Open:
$2.8
24h Volume:
1.44M
Relative Volume:
2.29
Market Cap:
$117.51M
Revenue:
$3.64M
Net Income/Loss:
$-87.37M
P/E Ratio:
-0.6842
EPS:
-4.37
Net Cash Flow:
$-86.46M
1W Performance:
+9.12%
1M Performance:
+19.60%
6M Performance:
-74.66%
1Y Performance:
-63.22%
1-Day Range:
$2.80
$3.02
1-Week Range:
$2.605
$3.02
52-Week Range:
$2.10
$14.22
Verastem Inc Stock (VSTM) Company Profile
Name
Verastem Inc
Sector
Industry
Phone
(781) 292-4200
Address
117 KENDRICK STREET, NEEDHAM, MA
Verastem Inc Stock (VSTM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-07-22 | Resumed | Alliance Global Partners | Buy |
| Apr-29-22 | Resumed | Cantor Fitzgerald | Overweight |
| Apr-14-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-09-22 | Initiated | Truist | Buy |
| Jul-01-21 | Initiated | Alliance Global Partners | Buy |
| May-24-21 | Upgrade | BTIG Research | Neutral → Buy |
| Jun-20-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-10-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-13-18 | Initiated | BTIG Research | Buy |
| May-02-18 | Initiated | Seaport Global Securities | Buy |
| Mar-08-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Sep-07-17 | Reiterated | H.C. Wainwright | Buy |
| Apr-13-17 | Initiated | Oppenheimer | Outperform |
| Mar-24-17 | Reiterated | H.C. Wainwright | Buy |
| Sep-29-15 | Downgrade | Cantor Fitzgerald | Buy → Hold |
| Sep-29-15 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-29-15 | Downgrade | Jefferies | Buy → Hold |
| Sep-29-15 | Downgrade | Raymond James | Strong Buy → Outperform |
| Sep-28-15 | Downgrade | Mizuho | Buy → Neutral |
| Sep-28-15 | Downgrade | ROTH Capital | Buy → Neutral |
| Sep-09-15 | Initiated | Raymond James | Strong Buy |
| May-12-15 | Reiterated | UBS | Buy |
| Apr-08-15 | Initiated | H.C. Wainwright | Buy |
| Jan-23-15 | Reiterated | ROTH Capital | Buy |
| Jul-08-14 | Resumed | Oppenheimer | Perform |
| Feb-11-14 | Initiated | Mizuho | Buy |
View All
Verastem Inc Stock (VSTM) Latest News
Verastem's SWOT analysis: oncology firm's stock faces pivotal phase - Investing.com
Verastem (NASDAQ:VSTM) Now Covered by Analysts at Guggenheim - MarketBeat
Verastem, Inc. (NASDAQ:VSTM) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Verastem CFO sells shares worth $257 to cover tax obligations By Investing.com - Investing.com Australia
Verastem CFO sells shares worth $257 to cover tax obligations By Investing.com - Investing.com South Africa
Verastem CFO sells shares worth $257 to cover tax obligations By Investing.com - Investing.com Canada
Verastem CFO sells shares worth $257 to cover tax obligations - Investing.com India
Verastem CFO sells shares worth $257 to cover tax obligations - Investing.com
Financial Analysis: Verastem Inc (VSTM)’s Ratios Unveil Key Insights - The Dwinnex
Does Verona Pharma Plc ADR (NASDAQ: VRNA) Still Look Hot This Week? - Stocks Register
Verona Pharma Plc ADR (VRNA) deserves closer scrutiny - US Post News
Evan/ Fa Jones Sells 5,173 Shares of Veracyte, Inc. (NASDAQ:VCYT) Stock - Defense World
Stock Surge: Viridian Therapeutics Inc (VRDN) Closes at 22.30, Marking a -0.89 Increase/Decrease - The Dwinnex
Are Smart Investors Making the Right Decision? Verastem Inc (VSTM) - SETE News
Victory Capital Management Inc. Makes New $527,000 Investment in Savara Inc (NASDAQ:SVRA) - Defense World
Verastem CEO sells shares worth $513 to cover tax obligations By Investing.com - Investing.com South Africa
Verastem director sells shares worth $365 to meet tax obligations By Investing.com - Investing.com Australia
Verastem director Brian Stuglik sells shares worth $937 By Investing.com - Investing.com South Africa
Verastem CEO sells shares worth $513 to cover tax obligations By Investing.com - Investing.com Australia
Verastem director Brian Stuglik sells shares worth $937 By Investing.com - Investing.com Australia
Verastem director sells shares worth $365 to meet tax obligations - Investing.com India
Verastem director sells shares worth $365 to meet tax obligations By Investing.com - Investing.com Canada
Verastem CEO sells shares worth $513 to cover tax obligations - Investing.com India
Verastem director sells shares worth $365 to meet tax obligations - Investing.com
Verastem CEO sells shares worth $513 to cover tax obligations By Investing.com - Investing.com Canada
Verastem CEO sells shares worth $513 to cover tax obligations - Investing.com
Verastem CEO sells shares worth $513 to cover tax obligations By Investing.com - Investing.com UK
Its Stock Has Paid Off Big Time For Valvoline Inc - SETE News
Resolute Capital Asset Partners LLC Invests $723,000 in Verona Pharma plc (NASDAQ:VRNA) - Defense World
Market Resilience: Verona Pharma Plc ADR (VRNA) Finishes Strong at 29.23, Up 0.14 - The Dwinnex
Verastem CEO sells shares worth $688 to cover taxes By Investing.com - Investing.com Australia
Verastem director sells company shares worth $803 By Investing.com - Investing.com Australia
Verastem director Brian Stuglik sells shares worth $1,680 By Investing.com - Investing.com Australia
Veracyte (NASDAQ:VCYT) Reaches New 52-Week High at $33.49 - Defense World
Verastem CEO sells shares worth $688 to cover taxes By Investing.com - Investing.com South Africa
Verastem director Brian Stuglik sells shares worth $1,680 By Investing.com - Investing.com South Africa
Verastem director sells company shares worth $803 By Investing.com - Investing.com South Africa
Verastem CEO sells shares worth $688 to cover taxes By Investing.com - Investing.com Canada
Verastem director sells company shares worth $803 By Investing.com - Investing.com Canada
Verastem director Brian Stuglik sells shares worth $1,680 - Investing.com India
Verastem director Brian Stuglik sells shares worth $1,680 By Investing.com - Investing.com Canada
Verastem CEO sells shares worth $688 to cover taxes - Investing.com
Verastem director sells company shares worth $803 By Investing.com - Investing.com UK
Valvoline Inc [VVV] Insider Activity: An Update for Investors - Knox Daily
Verastem director sells company shares worth $803 - Investing.com
Veracyte Inc (VCYT) Becoming More Attractive for Investors - Knox Daily
Is it possible to buy Verona Pharma Plc ADR(VRNA) shares at a good price now? - US Post News
Savara (NASDAQ:SVRA) Stock Price Up 6% - MarketBeat
What is Verona Pharma Plc ADR (VRNA) Stock Return on Shareholders’ Capital? - SETE News
Veracyte (NASDAQ:VCYT) Reaches New 1-Year High at $33.49 - MarketBeat
Vera Bradley Second Quarter 2025 Earnings: Misses Expectations - Simply Wall St
Verastem Inc Stock (VSTM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):